✦ LIBER ✦

P-212 Split-dose cisplatin (CDDP) and vinorelbine (VNR) in advanced non-small cell lung cancer (NSCLC): treatment outcomes including health-related quality of life (HRQL)

✍ Scribed by Lee, Christopher W.; Murray, Nevin; Murphy, Kevin; Williams, Chris; MacNeil, Mary V.; Martins, Heidi; Taylor, Marianne; Jones, Amanda; Khoo, Kong; Melosky, Barbara

Book ID: 118571913
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 184 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92181-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6501 ORAL Global Lung Oncology Branch tr

6501 ORAL Global Lung Oncology Branch trial 3 (GLOB 3): Quality of Life (QoL) results of a randomised multinational Phase III trial of oral and i.v. vinorelbine (NVB) plus cisplatin (CDDP) versus docetaxel (DTX) plus CDDP as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Rolski, J.; Grodzki, T.; Schneider, C.P.; Zatloukal, P.; Reck, M.; Aitini, E.; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

9143 Health-related quality of life (HRQ

✍ Page, R.; Blais, N.; Torigoe, Y.; Mundayat, R.; Ball, G.; Cappelleri, J.C.; Kim, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB